DIR Return Create A Forum - Home
---------------------------------------------------------
MS Speaks
HTML https://msspeaks.createaforum.com
---------------------------------------------------------
*****************************************************
DIR Return to: TYSABRI (natalizumab)
*****************************************************
#Post#: 2716--------------------------------------------------
(Abst.) Developing a model of care for home infusions of Tysabri
...
By: agate Date: November 8, 2019, 12:48 pm
---------------------------------------------------------
Some nursing researchers are studying developing a way to make
home infusions of Tysabri possible for people with MS.From
PubMed, November 8, 2019--"Developing a Model of Care for Home
Infusions of Natalizumab for people with Multiple Sclerosis":
HTML https://www.ncbi.nlm.nih.gov/pubmed/31693562
#Post#: 3355--------------------------------------------------
(Abst.) Home Tysabri infusions...a pilot randomized cross-over t
rial
By: agate Date: July 22, 2021, 11:15 am
---------------------------------------------------------
More on this--from PubMed (July 22, 2021)--"Home infusions of
natalizumab for people with multiple sclerosis: A pilot
randomised cross-over trial":
HTML https://pubmed.ncbi.nlm.nih.gov/34288591/
#Post#: 3362--------------------------------------------------
Re: At-home Tysabri infusions seem as safe and effective as thos
e at clinics
By: agate Date: July 31, 2021, 1:06 am
---------------------------------------------------------
This article in Multiple Sclerosis News Today (July 26, 2021)
discusses the study cited in the previous post--"At-home Tysabri
Infusions for RRMS Appear as Safe, Effective as Those at
Cinics":
HTML https://bit.ly/3ldqr6H
#Post#: 3983--------------------------------------------------
Re: (Abst.) Switching from hospital administration of natalizuma
b to at-home administration
By: agate Date: April 2, 2023, 1:23 am
---------------------------------------------------------
During the COVID-19 pandemic, for a year this group of
researchers administered natalizumab infusions in the
home for some 30 MS patients.
From PubMed (April 1, 2023)--"Switching from natalizumab
administration at the day hospital to administration at home
...":
HTML https://pubmed.ncbi.nlm.nih.gov/37001411/
#Post#: 4030--------------------------------------------------
Re: (Abst.) Risk management in a natalizumab home infusion proce
dure
By: agate Date: May 20, 2023, 1:35 am
---------------------------------------------------------
From PubMed (May 19, 2023)--"Evaluation of risk management in a
natalizumab home infusion procedure":
HTML https://pubmed.ncbi.nlm.nih.gov/37202259/
*****************************************************